GPAT vs MACI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 10, 2026
GPAT
50.0
AI Score
VS
GPAT Wins
MACI
46.9
AI Score
Investment Advisor Scores
MACI
47score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | GPAT | MACI | Winner |
|---|---|---|---|
| Net Income | 1.50M | 2.44M | GPAT |
| Operating Income | -1.37M | -2.03M | MACI |
| ROE | -43.0% | -15.0% | GPAT |
| ROA | 3.2% | 2.5% | MACI |
| Total Assets | 47.02M | 98.35M | GPAT |
| Cash | 2,068 | 571,765 | GPAT |
| Current Ratio | 0.70 | 0.05 | MACI |
Relative Price Performance (Last 90 Days)
GPAT 1M: +0.3%
· 3M: —
MACI 1M: +0.7%
· 3M: +1.5%
Current Technical Phase
GPAT
NeutralHold
Mixed signals - no dominant trend phase, RSI 52
MACI
NeutralHold
Mixed signals - no dominant trend phase, RSI 59
Fundamentals Snapshot
| Metric | GPAT | MACI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 0.0 |
| Trailing P/E | 44.6 | 61.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.0% |
| Gross Margin | — | — |
| Operating Margin | 0.0% | 0.0% |
| EPS | 0.25 | 0.18 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, GPAT is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.